Heart failure is a condition in which the heart is not able to pump enough blood throughout the body for its normal function. The cause of this can be either functional or structural disorder of the heart. Common causes of heart failure include cardiomyopathy, hypertension, heart valve problems and coronary artery disease. There is no cure for heart failure, but there are heart failure treatments that can improve your symptoms.
With respect to the heart, stem cells have the ability to not only home into the damaged areas but also to initiate a cascade of biological events which both culminate in healing of the heart muscle. For example, animal studies have demonstrated that stem cell therapy will cause new muscle cells to be formed through stimulation of dormant stem cells that are already inside the heart muscle. In these studies, the administered stem cell also transformed into new heart muscle cells.
At Cellular Hope Institute, our stem cell treatment for heart failure involves administration of mesenchymal stem cells harvested from human umbilical cord tissue.
Through administration of mesenchymal stem cells, we have observed improvements in heart failure patients treated at our facilities. Contact us to learn more about chronic heart failure treatment at our clinic in Mexico.
Heart failure is a condition in which the heart is not able to pump enough blood throughout the body for its normal function. The cause of this can be either functional or structural disorder of the heart. Common causes of heart failure include cardiomyopathy, hypertension, heart valve problems and coronary artery disease. There is no cure for heart failure.
With respect to the heart, stem cells have the ability to not only home into the damaged areas but also to initiate a cascade of biological events which both culminate in healing of the heart muscle. For example, animal studies have demonstrated that stem cell therapy will cause new muscle cells to be formed through stimulation of dormant stem cells that are already inside the heart muscle. In these studies, the administered stem cell also transformed into new heart muscle cells.
At Cellular Hope Institute, our stem cell treatment protocol for heart failure involves administration of mesenchymal stem cells harvested from human umbilical cord tissue.
Through administration of mesenchymal stem cells, we have observed improvements in heart failure patients treated at our facilities.
Experience our Individually-Center approach for deep regeneration and wellbeing through our leading-edge cellular therapies
The adult stem cells used for heart regeneration at the Cellular hope institute come from human umbilical cord tissue (allogeneic mesenchymal). These stem cells are expanded at our Center in Cancun state-of-the-art laboratory.
The mesenchymal stem cells we use are recovered from donated umbilical cords following normal, healthy births. Each mother has her medical history screened and is tested for infectious diseases. Proper consent is received from each family prior to donation.
All umbilical cord-derived stem cells are screened for infectious diseases to International Blood Bank Standards before they are cleared for use in patients.
Only a small percentage of donated umbilical cords pass our rigorous screening process.
Since HUCT mesenchymal stem cells are immune system privileged, cell rejection is not an issue and Human Leukocyte Antigen (HLA) matching is not necessary.
The stem cells with the best anti-inflammatory activity, immune modulating capacity, and ability to stimulate regeneration can be screened and selected.
Allogeneic stem cells can be administered multiple times over the course of days in uniform dosages that contain high cell counts.
Umbilical cord tissue provides an abundant supply of mesenchymal stem cells.
No need to collect stem cells from the patient’s hip bone or fat under anesthesia, which especially for small children and their parents, can be an unpleasant ordeal.
There is a growing body of evidence showing that umbilical cord-derived mesenchymal stem cells are more robust than mesenchymal stem cells from other sources.
No need to administer chemotherapy drugs like Granulocyte-colony stimulating factor (G-CSF or GCSF) to stimulate the bone marrow to produce granulocytes and stem cells and release them into the bloodstream. Continue reading to learn more about our stem cell treatment for heart failure.
Human umbilical cord tissue-derived mesenchymal stem cells (MSCs) that were isolated and grown in our laboratory in Cancun, Mexico to create master cell banks are currently being used in the United States under US FDA regulation.
These cells serve as the starting material for cellular products used in MSC clinical trials for two Duchenne’s muscular dystrophy patients under US FDA’s designation of Investigational New Drug (IND) for single patient compassionate use. (IND 16026 DMD Single Patient).
The body’s immune system is unable to recognize umbilical cord-derived mesenchymal stem cells as foreign and therefore they are not rejected. HUCT stem cells have been administered thousands of times at the Cellular Hope Institute and there has never been a single instance rejection (graft vs. host disease). As a matter of fact, allogeneic (not the patient’s own) mesenchymal stem cells are approved to treat graft vs. host disease in Canada and New Zealand.
Umbilical cord-derived mesenchymal stem cells also proliferate/differentiate more efficiently than “older” cells, such as those found in the fat and therefore, they are considered to be more “potent”.
The umbilical cord-derived stem cells are administered intravenously by a licensed physician for an effective stem cell treatment for heart failure.
Treatment protocol with stem cells for heart regeneration and failure will be assigned by staff physicians after the patient has submitted all requested medical information and received approval. A patient’s recommended protocol may differ from the example given below.
Treatment duration: 4 days and 5 nights
- Physical examination and blood testing: Monday.
- 3 IV injections of expanded allogeneic (low-passage) mesenchymal stem cells.
- 8 intramuscular injections of expanded allogeneic mesenchymal stem cells.
- Stem-kine supplement for 1 month (only after medical evaluation in Cancun Mexico).
Our medical staff will be contacting you at regular intervals to see how you are doing. Periodic follow-up also helps us evaluate overall treatment efficacy. Therefore, our medical staff will follow up with you after 1 month, 3 months, 6 months, and 1 year.
0
Years of Service
0
Assisted Patients
0
Years of Service
0
Assisted Patients
Contact Us to discuss your treatment at Cellular Hope Institute
Contact Us to discuss your treatment at Cellular Hope Institute
FAQ
Stem cell therapy for heart failure aims to regenerate damaged cardiac tissue and improve heart function. This is achieved by injecting stem cells that can differentiate into cardiac cells, potentially enhancing heart muscle regeneration and promoting blood vessel growth. The goal is to improve heart pump efficiency and reduce symptoms. However, the degree of improvement varies, and ongoing research is crucial to establish efficacy.
For treating heart failure, several types of stem cells are used, including mesenchymal stem cells (MSCs), cardiac stem cells, and bone marrow-derived mononuclear cells. These cells are believed to aid in repairing damaged heart tissue and improving cardiac function by promoting the regeneration of heart muscle and enhancing blood vessel growth. Each type has unique properties and potential benefits for heart repair.
The success rate of stem cell therapy for heart failure varies and is still under extensive study. Early clinical trials have shown moderate improvements in cardiac function and symptoms in some patients, but results are not uniform across all studies. Success often depends on the type of stem cells used, the method of delivery, and the specific characteristics of the patient’s heart condition. Further research is needed to determine overall efficacy.
Stem cell therapy cannot completely cure heart failure, as it is a chronic condition with complex underlying causes. However, it can potentially improve symptoms and heart function by promoting the repair and regeneration of heart tissue. The therapy aims to enhance quality of life and functional capacity, reducing symptoms like fatigue and breathlessness. The extent of improvement varies among individuals.